You can buy or sell Novartis and other stocks, options, and ETFs commission-free!
Novartis AG, also called Novartis, is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products including active pharmaceutical ingredients. The Corporate segment refers to group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland. The listed name for NVS is Novartis AG.
Basel, Basel-Stadt (Basle Town)
52 Week High
52 Week Low
Novartis Kicks Off $2.5B Share Buyback Program On Strong Pipeline Growth
On Tuesday, Swiss biopharma company Novartis AG (NYSE: NVS) announced a $2.5 billion share buyback program. The management also exhibited a heightened confidenc
Novartis to repurchase up to $2.5 billion shares
Novartis AG said Tuesday it is initiating a share-buyback program of up to $2.5 billion that will start immediately and last into the first half of 2021. The S
— per share
Available Jan 26, Pre-Market